S100 beta protects hippocampal neurons from damage induced by glucose deprivation.
S100 beta is a calcium-binding protein elevated in Down's syndrome and Alzheimer's disease. Previous studies have demonstrated that S100 beta is trophic for several neuronal populations. We tested the influence of S100 beta on hippocampal neurons. The initial response included a rapid increase in [Ca2+]i similar to that elicited by S100 beta in other populations. S100 beta also substantially decreased cell death and loss of mitochondrial function resulting from glucose deprivation. Therefore, S100 beta exerts a neuroprotective influence on CNS neurons, suggesting that its elevation in neurological disorders may be a compensatory response.
Barger
S W
SW
Sanders-Brown Center on Aging, University of Kentucky, Lexington 40536-0230, USA.
Van Eldik
L J
LJ
Mattson
M P
MP
D000818:Animals; D002120:Calcium Channel Agonists / Q000494:pharmacology; D016923:Cell Death / Q000187:drug effects; D002478:Cells, Cultured; D005947:Glucose / Q000502:physiology*; D006624:Hippocampus / Q000166:cytology* / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects; D009423:Nervous System Neoplasms / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism; D009474:Neurons / Q000187:drug effects*; D017966:Pyramidal Cells / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D009418:S100 Proteins / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D002120:Calcium Channel Agonists; D009418:S100 Proteins; D005947:Glucose